COSM PE Ratio & Valuation,Is COSM Overvalued

COSM Relative Valuation

COSM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, COSM is overvalued; if below, it's undervalued.

Historical Valuation

Cosmos Health Inc (COSM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.23 is considered Fairly compared with the five-year average of 7.43. The fair price of Cosmos Health Inc (COSM) is between 0.25 to 0.58 according to relative valuation methord.

Relative Value

Fair Zone

0.25-0.58

Current Price：0.42

Fair

43.59

10.19

EV/EBITDA

Cosmos Health Inc. (COSM) has a current EV/EBITDA of 10.19. The 5-year average EV/EBITDA is -1.53. The thresholds are as follows: Strongly Undervalued below -20.28, Undervalued between -20.28 and -10.91, Fairly Valued between 7.84 and -10.91, Overvalued between 7.84 and 17.21, and Strongly Overvalued above 17.21. The current Forward EV/EBITDA of 10.19 falls within the Overvalued range.

63.50

EV/EBIT

Cosmos Health Inc. (COSM) has a current EV/EBIT of 63.50. The 5-year average EV/EBIT is 6.15. The thresholds are as follows: Strongly Undervalued below -39.40, Undervalued between -39.40 and -16.62, Fairly Valued between 28.93 and -16.62, Overvalued between 28.93 and 51.70, and Strongly Overvalued above 51.70. The current Forward EV/EBIT of 63.50 falls within the Strongly Overvalued range.

0.23

Cosmos Health Inc. (COSM) has a current PS of 0.23. The 5-year average PS is 0.21. The thresholds are as follows: Strongly Undervalued below -0.29, Undervalued between -0.29 and -0.04, Fairly Valued between 0.46 and -0.04, Overvalued between 0.46 and 0.71, and Strongly Overvalued above 0.71. The current Forward PS of 0.23 falls within the Historic Trend Line -Fairly Valued range.

8.48

P/OCF

Cosmos Health Inc. (COSM) has a current P/OCF of 8.48. The 5-year average P/OCF is 0.30. The thresholds are as follows: Strongly Undervalued below -18.14, Undervalued between -18.14 and -8.92, Fairly Valued between 9.52 and -8.92, Overvalued between 9.52 and 18.74, and Strongly Overvalued above 18.74. The current Forward P/OCF of 8.48 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Cosmos Health Inc. (COSM) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Cosmos Health Inc (COSM) has a current Price-to-Book (P/B) ratio of 0.60. Compared to its 3-year average P/B ratio of 0.63 , the current P/B ratio is approximately -5.19% higher. Relative to its 5-year average P/B ratio of 9.90, the current P/B ratio is about -93.94% higher. Cosmos Health Inc (COSM) has a Forward Free Cash Flow (FCF) yield of approximately -50.64%. Compared to its 3-year average FCF yield of -77.08%, the current FCF yield is approximately -34.30% lower. Relative to its 5-year average FCF yield of -61.55% , the current FCF yield is about -17.73% lower.

0.60

P/B

Median3y

0.63

Median5y

9.90

-50.64

FCF Yield

Median3y

-77.08

Median5y

-61.55

Competitors Valuation Multiple

The average P/S ratio for COSM's competitors is 0.04, providing a benchmark for relative valuation. Cosmos Health Inc Corp (COSM) exhibits a P/S ratio of 0.23, which is 500% above the industry average. Given its robust revenue growth of 37.86%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of COSM decreased by 34.02% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -17.59 to -31.28.

The secondary factor is the Revenue Growth, contributed 37.86%to the performance.

Overall, the performance of COSM in the past 1 year is driven by Margin Expansion. Which is more sustainable.

37.86%

12.41M → 17.11M

Revenue Growth

77.83%

-17.59 → -31.28

Margin Expansion

-149.71%

1.27 → -0.63

P/E Change

-34.02%

0.67 → 0.44

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Cosmos Health Inc (COSM) currently overvalued or undervalued?

What is Cosmos Health Inc (COSM) fair value?

COSM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Cosmos Health Inc (COSM) is between 0.25 to 0.58 according to relative valuation methord.

How does COSM's valuation metrics compare to the industry average?

The average P/S ratio for COSM's competitors is 0.04, providing a benchmark for relative valuation. Cosmos Health Inc Corp (COSM) exhibits a P/S ratio of 0.23, which is 500.00% above the industry average. Given its robust revenue growth of 37.86%, this premium appears sustainable.

What is the current P/B ratio for Cosmos Health Inc (COSM) as of Dec 15 2025?

As of Dec 15 2025, Cosmos Health Inc (COSM) has a P/B ratio of 0.60. This indicates that the market values COSM at 0.60 times its book value.

What is the current FCF Yield for Cosmos Health Inc (COSM) as of Dec 15 2025?

As of Dec 15 2025, Cosmos Health Inc (COSM) has a FCF Yield of -50.64%. This means that for every dollar of Cosmos Health Inc’s market capitalization, the company generates -50.64 cents in free cash flow.

What is the current Forward P/E ratio for Cosmos Health Inc (COSM) as of Dec 15 2025?

As of Dec 15 2025, Cosmos Health Inc (COSM) has a Forward P/E ratio of 43.59. This means the market is willing to pay $43.59 for every dollar of Cosmos Health Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Cosmos Health Inc (COSM) as of Dec 15 2025?

As of Dec 15 2025, Cosmos Health Inc (COSM) has a Forward P/S ratio of 0.23. This means the market is valuing COSM at $0.23 for every dollar of expected revenue over the next 12 months.

COSM Valuation